The pharmacology of cell differentiation : proceedings of the Esteve Foundation Symposium V, Son Vida, Mallorca, 12-15 October, 1992
著者
書誌事項
The pharmacology of cell differentiation : proceedings of the Esteve Foundation Symposium V, Son Vida, Mallorca, 12-15 October, 1992
(Esteve Foundation symposia, v. 5)(International congress series, no. 1016)
Excerpta Medica, 1993
大学図書館所蔵 全7件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes indexes
内容説明・目次
内容説明
The symposium on "The Pharmacology of Cell Differentiation", upon which this text is based, has been structured to begin with an exploration, first of general, then more specific mechanisms implicated in the inter- and intra-cellular systems exploited by cells for the transduction of growth and developmental signals; then to examine the intracellular machinery for cell growth regulation, the gene-expression control mechanisms identified in transformed and normal cells; and finally to move to selected examples illustrating the exploitation of these findings for the induction of developmental changes in real cancers. This is not a review of established successes in cancer therapy; rather it is a progress report on work on-going at one of the frontiers of contemporary pharmacology.
目次
Part 1 Signalling: General mechanisms - Signal transduction by the mitogenic phospholipid, lysophosphatidic acid (W.H. Moolenaar et al.). The roles of specific isoforms of protein kinase C (PKC) in growth control, oncogene-induced cell transformation, and differentiation (I.B. Weinstein et al.). Role of Ras proteins in T cell activation (J. Downward). Part 2 Signalling: Growth factors and receptors. TGF-B and myogenesis: Interference with cell cycle G1, phase progression may lead to differentiation (A. Zentella, J. Massaugue). Role of MAP kinases in the control of cell proliferation (G. Pages et al.). The erythropoietin receptor - Structure, activation and tumourigenesis (H.F. Lodish). The kit-ligand (steel factor) and it's receptor c-kit: Pleiotropic roles in cell growth, cell survival and cell migration - Insights from germline mutations (P. Besmer et al.). Part 3 Cell cycle control mechanisms and tumour suppressors. Switching genes on at the start of the yeast cell cycle (S. Sockanathan et al.). Mechanisms of action of p53 (Y. Barak et al.). The role of tumor suppressor genes in cancer and development (L. Fiszer-Maliszewska, S.H. Friend). Part 4 Regulation of gene expression. Effects of myc expression on mouse myoblasts are reversed in mixed culture with normal cells (M. Crescenzi, D. Crouch, F. Tato). Id as a general negative regulator of the Helix-Loop-Helix family of DNA-binding proteins (R. Benezra). Molecular genetics of acute promyelocytic leukemia: The t(15,17) translocation (H. de The et al.). Retinoic acid and human teratocarcinoma differentiation (J.M. Kurie, E. Dmitrovsky). Part 5 Differentiation inducing agents. Induced differentiation: Molecular mechanism and therapeutic potential (R.A. Rifkind, P.A. Marks). Vitamin D3 analogs and hematopoiesis (Y. Imai, P. Koeffler). The design of differentiation therapies (G.E. Francis). Synergism between differentiation agents: Preclinical and clinical studies in myeloid leukaemia (H.T. Hassan).
「Nielsen BookData」 より